A61K - Preparations for medical, dental, or toilet purposes

More topics under "A61K - Preparations for medical, dental, or toilet purposes" (2,585,043)
A61K 101 - Radioactive non-metals (526)
A61K 103 - Radioactive metals (481)
A61K 125 - Containing or obtained from roots, bulbs, tubers, corms or rhizomes (2,645)
A61K 127 - Containing or obtained from leaves (1,806)
A61K 129 - Containing or obtained from bark (325)
A61K 131 - Containing or obtained from seeds, nuts, fruits or grains (1,932)
A61K 133 - Containing or obtained from flowers or blossoms (665)
A61K 135 - Containing or obtained from stems, stalks, branches, twigs or shoots (756)
A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
A61K 33 - Medicinal preparations containing inorganic active ingredients (56,213)
A61K 35 - Medicinal preparations containing material or reaction products thereof with undetermined constitution (125,838)
A61K 36 - Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines (179,316)
A61K 38 - Medicinal preparations containing peptides (316,240)
A61K 39 - Medicinal preparations containing antigens or antibodies (182,248)
A61K 41 - Medicinal preparations obtained by treating materials with wave energy or particle radiation (9,445)
A61K 45 - Medicinal preparations containing active ingredients not provided for in groups (115,020)
A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128)
A61K 48 - Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy (86,964)
A61K 49 - Preparations for testing in vivo (35,376)
A61K 50 - Electrically conductive preparations for use in therapy or testing in vivo, e.g. conductive adhesives or gels to be used with electrodes for electrocardiography (ecg) or for transcutaneous drug administration (62)
A61K 51 - Preparations containing radioactive substances for use in therapy or testing in vivo (24,291)
A61K 6 - Preparations for dentistry (18,259)
A61K 8 - Cosmetics or similar toilet preparations (170,551)
A61K 9 - Medicinal preparations characterised by special physical form (299,044)

Patents for A61K - Preparations for medical, dental, or toilet purposes (29,449)
12/2006
12/06/2006	EP1207740B1 Texturized cellulosic and lignocellulosic materials and compositions and composites made therefrom
12/06/2006	CN1875028A Seneca valley virus based compositions and methods for treating disease
12/06/2006	CN1874991A Compound capable of binding S1P receptor and pharmaceutical use thereof
12/06/2006	CN1874782A RAGE-related methods and compositions for treating glomerular injury
12/06/2006	CN1874781A Compositions of botanical extracts for cancer therapy
12/06/2006	CN1874679A Delivery of physiological agents with in-situ gels comprising anionic polysaccharides
12/06/2006	CN1872869A Nucleosides analogues, such as antivirals including inhibitors of retroviral reverse transcriptase and the DNA polymerase
12/06/2006	CN1287774C Composition for inhalation
12/06/2006	CN1287769C Dispersible phospholipid stabilzed microparticles
12/05/2006	US7145019 Biotinated macromolecules having protein reactive groups that react with functional groups on proteins including sulfhydryl and amine groups, used in the detection and isolation of targets from heterologous mixtures
12/05/2006	US7144914 3,7-diazabicyclo[3.3.0]octanes and their use in the treatment of cardiac arrhythmias
12/05/2006	US7144911 Anti-inflammatory medicaments
12/05/2006	US7144883 Substituted fused ring sulfonamides containing, e.g., naphthalene, isoquinoline, quinoline, benzofuran or benzothiophene rings; treatment of conditions relating to obesity, type II diabetes and CNS disorders
12/05/2006	US7144845 Compounds useful in the manufacture of an anti-inflammatory androstane derivative
12/05/2006	US7144727 comprises two culture compartments in fluid communication with each other and each culture compartment is transversed by a filter that prevents the exit of the cells
12/05/2006	US7144707 Determination of risk and treatment of complications of prematurity
12/05/2006	US7144580 M. haemolytica outer membrane protein P1pE as a vaccine or vaccine component against shipping fever
12/05/2006	CA2203079C 2-phenyl-1-[4-(2-aminoethoxy)-benzyl]indoles as estrogenic agents
11/2006
11/30/2006	WO2005046591A3 Electrically activated alteration of body tissue stiffness for breathing disorders
11/30/2006	WO2005039488A3 Use of cxcr4 protein expression on the surface of stem cells as a marker for tumor tropic potential
11/30/2006	WO2005020919A3 Method of treatment and bioassay involving macrophage migration inhibitory factor (mif) as cardiac-derived myocardial depressant factor
11/30/2006	WO2005009379A3 Polypeptides for inducing a protective immune response against staphylococcus aureus
11/30/2006	WO2004112720A3 Antiviral compositions and methods of using the same
11/30/2006	WO2004047728A3 Compositions and methods for the treatment of immune related diseases
11/30/2006	US20060270736 Ternary and quaternary eutectic mixtures of local anesthetics substances
11/30/2006	US20060270733 2-Aminobenzoyl derivatives
11/30/2006	US20060270715 Dosage forms of amlodipine and processes for their preparation
11/30/2006	US20060270710 Methods for inhibition of angiogenesis
11/30/2006	US20060270673 Inhibitors of akt activity
11/30/2006	US20060270621 Inhibition of hair growth with RNAi targeting desmoglein 4 and nude mRNAs
11/30/2006	US20060269923 High-throughput screening of libraries of compounds to identify pharmaceutical leads useful for preventing, treating, managing and/or ameliorating a fungal infection/infestation; assays for the identification of compounds that inhibit or reduce the activity of a fungal tRNA splicing endonuclease
11/30/2006	US20060269631 inhibit, block, and/or prevent metastasis of carcinogenic cells away from a primary cancer site
11/30/2006	US20060269621 Novel therapeutic extracts and molecules for degenerative conditions
11/30/2006	US20060269603 Controlled release tramadol formulations
11/30/2006	US20060269552 Heparanase activity neutralizing anti-heparanase monclonal antibody and other anti-heparanase antibodies
11/29/2006	EP1725209A2 Topical composition
11/29/2006	EP1648408A4 Azepine derivatives as pharmaceutical agents
11/29/2006	EP1648389A4 Biological engineering of articular structures containing both cartilage and bone
11/29/2006	EP1162999B1 Vaccine against Streptococcus pneumoniae
11/29/2006	CN1871342A P18 in stem cell manipulations
11/29/2006	CN1871278A Water-soluble polyamioamides as sunscreen agents
11/29/2006	CN1871249A Thermally stable crystalline epirubicin hydrochloride and method of making the same
11/29/2006	CN1871034A Methods and compositions for cancer therapy using a novel adenovirus
11/29/2006	CN1871021A Treating or preventing restless legs syndrome using prodrugs of GABA analogs
11/29/2006	CN1871003A Polymorphic forms of 3-(4-amino-1-oxo-1,3 dihydro-isoindol-2-yl)-piperidine-2,6-dione
11/29/2006	CN1870990A Fused phenylalanine derivatives as dipeptidyl peptidase-iv inhibitors for the treatment or prevention of diabetes
11/29/2006	CN1870972A Cosmetic composition comprising camel milk or components thereof
11/29/2006	CN1870962A Stable aluminum / zirconium antiperspirant solution
11/29/2006	CN1869061A Peptidomimetic protease inhibitors
11/29/2006	CN1868458A Controlled release composition and method of producing the same
11/28/2006	US7141696 N-alkyl-diphenyl-alkylene-amine derivatives; for the treatment of smooth muscle hyperactivity in urinary incontinence, gastrointestinal disorder, respiratory system disorder; promoting smooth muscle relaxation, reducing hypotension or cardiac side effects
11/28/2006	US7141607 Topically administering Hydroxamic acid matrix metalloproteinase inhibitors such as batimastat to the eye
11/28/2006	US7141604 Administering to a patient citalopram or salts to treat hypertension and hypotension
11/28/2006	US7141565 Substituted quinobenzoxazine analogs
11/28/2006	CA2227252C Hand cleanser comprising a blend of paramenthadienes
11/23/2006	WO2006124587A2 Device for stabilizing an arm
11/23/2006	WO2006124161A1 Sustained release l-arginine formulations and methods of manufacture and use
11/23/2006	WO2005030147A3 Methods of using ammonia oxidizing bacteria
11/23/2006	US20060264626 INHIBITORS OF FACTOR Xa AND OTHER SERINE PROTEASES INVOLVED IN THE COAGULATION CASCADE
11/23/2006	US20060264486 (5-{3-[4-(4,5,6,7-tetrahydro-benzooxazol-2-yl)-phenoxy]-propoxy}-indol-1-yl)-acetic acid; diabetes, obesity, hyperlipidemia, and atherosclerotic disease
11/23/2006	US20060264479 Nicotinamide Derivatives Useful as p38 Inhibitors
11/23/2006	US20060264449 Compounds for modulation of kinesins as anticancer agents with administering
11/23/2006	US20060264424 Arylsulfonamidobenzylic compounds
11/23/2006	US20060264392 Modulators of angiogenesis
11/23/2006	US20060264354 Cop 1 for treatment of inflammatory bowel diseases
11/23/2006	US20060263772 Identification of anti-hiv compounds inhibiting virus assembly and binding of nucleocapsid protein to nucleic acid
11/23/2006	US20060263423 Product and process for increasing compactibility of carbohydrates
11/23/2006	US20060263360 Compositions and methods for delivering thymosin beta 4, analogues, isoforms and other derivatives
11/23/2006	US20060263351 Methods and compositions for protection against thrombolysis associated reperfusion injury
11/23/2006	US20060263344 Novel probiotic compositions and methods of using the same
11/23/2006	US20060263301 In situ gelling self-reactive materials for embolization
11/23/2006	CA2604568A1 Sustained release l-arginine formulations and methods of manufacture and use
11/22/2006	EP1722818A2 Photoreactive compound specifically binding to calcium binding proteins
11/22/2006	EP1722802A1 A medical solution, a method for producing said medical solution and use thereof
11/22/2006	EP1722800A1 A medical solution, a method for producing said medical solution and use thereof
11/22/2006	EP1722739A2 Keratin gel and the types 2, 4 and 6 of collagens of frog protein for topical use or for lamina preparation use, such as dressing or powdering in food and complements use and in cosmetic mask manufacturing or in solutions used in cosmetic formulation and medical/pharmaceutical
11/22/2006	EP1638910A4 Color stabilization of hydroquinone hydroxyethyl ether products
11/22/2006	EP1603518A4 Poss and eposs containing cosmetics and personal care products
11/22/2006	EP1558080A4 Methods of preventing morbidity and mortality by perioperative administration of a blood clotting inhibitor
11/22/2006	EP1556694A4 Method of isolation and self-assembly of small protein particles from blood and other biological materials
11/22/2006	EP1511851A4 Method for identification of biologically active agents
11/22/2006	CN1867550A Compositions and methods for reducing the risk of epileptic occurrence and/or for treatment of seizure disorders
11/22/2006	CN1867349A Composition and method of treatment for urogenital conditions
11/22/2006	CN1867345A Therapeutic agent for periodontal disease
11/22/2006	CN1867338A Bicyclic [3.1.0] derivatives as glycine transporter inhibitors
11/22/2006	CN1865449A 病毒株 Strains
11/21/2006	US7138524 Processes for preparing anhydrous and hydrate forms of antihistaminic piperidine derivatives, polymorphs and pseudomorphs thereof
11/21/2006	US7138411 Substituted benzopyran derivatives for the treatment of inflammation
11/21/2006	US7138255 Method of isolation and self-assembly of small protein particles from blood and other biological materials
11/21/2006	CA2334718C Quinoline derivatives
11/21/2006	CA2253736C Antimicrobial treatment for herpes simplex virus and other infectious diseases
11/21/2006	CA2248604C An aphrodisiac for application to the sexual organs
11/21/2006	CA2154063C Treatment of h. pylori associated gastroduodenal disease
11/16/2006	WO2004089287A3 Spray dry coacervation systems and methods
11/16/2006	US20060258862 Famciclovir intermediate; reaction with diethyl malonate, reduction, esterification with acetic anhydride
11/16/2006	US20060258716 Methods and compositions for the treatment of helicobacter pylori-associated diseases using endoperoxide bridge-containing compounds
11/16/2006	US20060258692 Quinazolinone compositions for regulation of gene expression related to pathological processes
11/16/2006	US20060258668 Use of phosphatase inhibitors as adjunct therapy for psychiatric disorders
11/16/2006	US20060258656 Compositions and methods for treating cancer
11/16/2006	US20060258648 9-Azabicyclo'3.3.1 inon-6-ee derivatives with a heteroatom at the 3-position as renin inhibitors

1 ... 59 60 61 62 63 64 65 66 67 68 69 70 71 72 73 74 75 76 77 78 79 ... 295